Your browser doesn't support javascript.
loading
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.
Park, Won; Yoo, Dae Hyun; Miranda, Pedro; Brzosko, Marek; Wiland, Piotr; Gutierrez-Ureña, Sergio; Mikazane, Helena; Lee, Yeon-Ah; Smiyan, Svitlana; Lim, Mie-Jin; Kadinov, Vladimir; Abud-Mendoza, Carlos; Kim, HoUng; Lee, Sang Joon; Bae, YunJu; Kim, SuYeon; Braun, Jürgen.
Afiliação
  • Park W; IN-HA University, School of Medicine, Medicine/Rheumatology, Incheon, Republic of Korea.
  • Yoo DH; Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Miranda P; Universidad de Chile and Centro de Estudios Reumatologicos, Santiago de Chile, Chile.
  • Brzosko M; Department of Rheumatology and Internal Diseases, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Wiland P; Medical University of Wroclaw, Wroclaw, Poland.
  • Gutierrez-Ureña S; Department of Rheumatology, Hospital Civil de Guadalajara "Fray Antonio Alcalde" CUCS, Universidad de Guadalajara, Guadalajara Jalisco, Mexico.
  • Mikazane H; Outpatient Clinic 'ORTO', Riga, Latvia.
  • Lee YA; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Smiyan S; I.Ya. Horbachevsky Ternopil State Medical University, Municipal Institution of Ternopil Regional Council "Ternopil University Hospital", Ternopil, Ukraine.
  • Lim MJ; IN-HA University, School of Medicine, Medicine/Rheumatology, Incheon, Republic of Korea.
  • Kadinov V; Multiprofile Hospital for Active Treatment 'Sv. Marina', Varna, Bulgaria.
  • Abud-Mendoza C; Hospital Central and Faculty of Medicine, Universidad Autónoma de San Luis Potosi, San Luis Potosi, Mexico.
  • Kim H; CELLTRION, Incheon, Republic of Korea.
  • Lee SJ; CELLTRION, Incheon, Republic of Korea.
  • Bae Y; CELLTRION, Incheon, Republic of Korea.
  • Kim S; CELLTRION, Incheon, Republic of Korea.
  • Braun J; Rheumazentrum Ruhrgebiet, Herne, Germany.
Ann Rheum Dis ; 76(2): 346-354, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27117698
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Substituição de Medicamentos / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Substituição de Medicamentos / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2017 Tipo de documento: Article